Sectoral Asset Management Inc. is a leading investment management firm specializing in global thematic investing. The company focuses on identifying long-term trends and investing in companies that are well-positioned to benefit from these trends. With a research-driven approach, Sectoral aims to deliver superior risk-adjusted returns for its clients.

Sectoral Asset Management Inc.

Founded in 2000, Sectoral Asset Management Inc. is an industry-leading specialist in managing global investment portfolios in the healthcare sector.

Mission: 
Sectoral Asset Management is exclusively focused on managing global healthcare portfolios. Our objective is to achieve superior returns for our investors by concentrating on primary research.

We strive to provide unparalleled service to our investors.
We actively champion and maintain the highest educational and quality standards.

Our firm is 100% employees owned.

Sectoral's investment philosophy is based on fundamental research in the healthcare sector. This means that our investment team must have multiple areas of expertise. Sectoral's investment professionals have managed healthcare/biotechnology portfolios for over twelve years. All members of our team are CFA charterholders or candidates and most have earned postgraduate degrees in both business and science.

Sectoral Asset Management focuses on four main portfolio strategies:
Biotech
Healthcare
Emerging Markets
Small & Mid-Cap Healthcare 






Intellia Therapeutics

Mineralys Therapeutics

Better Therapeutics

Advaxis

Amolyt Pharma

Apellis Pharmaceuticals

Aprea

Babylon

Cogent Biosciences

Viracta Therapeutics

RainDance Technologies

Checkmate Pharmaceuticals

REGENXBIO

Shockwave Medical

Sectoral Asset Management

Sectoral Asset Management est heureux d’avoir contribué à la première conférence de la série Les Grands de l'industrie par MEDTEQ+ permettant aux entrepreneurs de côtoyer les grands joueurs de l'industrie des technologies en santé. 
 
Nous avons eu le privilège d'accueillir Betsabeh MadaniHermann, graduée de The University of British Columbia et anciennement se Mitacs, mais maintenant cheffe de la recherche mondiale pour Philips.
 
Merci à tous ceux qui ont collaboré à l'organisation de l'événement! Maxime Ranger, Josée Laflamme, Annie-Kim Gilbert, ROBIC, Espace CDPQ. 
 
----------------------------------------------------------------------------------
 
Sectoral Asset Management is pleased to have contributed to the first event of the Industry Leaders conference series by MEDTEQ+, bringing entrepreneurs face-to-face with key individuals in the medtech industry. 

We had the privilege of hosting Betsabeh MadaniHermann, The University of British Columbia graduate and formerly of Mitacs, now Head of Global Research for Philips.

Thanks to all that were instrumental in organising this first conference! Maxime Ranger, Josée Laflamme, Annie-Kim Gilbert, ROBIC, Espace CDPQ. 

The firm hosted another successful edition of its Healthcare Study Trip, the 21st, and had the great honour of having the Honourable Pierre Fitzgibbon, Minister of Economy, Innovation and Energy announce the first close of its new Fonds Medtech Ventures, with initial committed capital of CAD 41.5m. We are proud to partner with the Government of Quebec and Investissement Québec as well as Fonds de solidarité FTQ and private investors in this new endeavour. We continue to work towards a target fund size of CAD 100m and are excited to begin our work with promising medical technology companies in Quebec and the rest of the country.

We are honored to receive the 2023 Refinitiv Lipper Award for the Sectoral Healthcare Opportunities Fund, as Best Fund over 3 Years in the UK, Equity Sector Healthcare category.
Our heartfelt congratulations to Marco Cianflone, CFA, Senior Portfolio Manager, and the Investment Team.
This recognition awards the long-term investment approach and the teamwork of Sectoral Asset Management Investment Professionals. #healthcare

We are honored to receive the 2023 Refinitiv Lipper Award for the Sectoral Healthcare Opportunities Fund, as Best Fund over 3 Years in Austria, Equity Sector Healthcare category.
Our heartfelt congratulations to Marco Cianflone, CFA, Senior Portfolio Manager, and the Investment Team.
This recognition awards the long-term investment approach and the teamwork of Sectoral Asset Management Investment Professionals. #healthcare

Metric
Company Name	Sectoral Asset Management Inc.
Symbol
MSH ID	COM:SECTORAL
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Financial Services
Country	CA
Stage
Employee Count	35
Website	sectoral.com
LinkedIn	sectoral-asset-management
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:SECTORAL

Sectoral Asset Management Inc.

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue